|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / cwpKdXntPDxwCWfy |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Aaron Гость |
Добавлено: 14-06-2022 07:38 |
|
Can I call you back? ivermectina comp Faisal Janjua, the general manager for HFA Healthcare, said: “Our only commercial option, as the licence had been cancelled, was to supply as an unlicensed product. Any business has to recoup significant capital outlay so the price was modified. Another reason for the higher price is that we intend over time to re-licence the product. There are significant costs to re-licence.” |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / cwpKdXntPDxwCWfy |